Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Overexpression of the Ets-1 transcription factor in human breast cancer
2004
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
2011 StandoutNobel
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
2000
E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors
2007
Differential Inactivation of Caspase-8 in Lung Cancers
2002
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Novel Strategies for the Early Detection and Prevention of Lung Cancer
2005
Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung
2001
Vascular endothelial growth factor receptor‐1 in human cancer
2010
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The 2004 World Health Organization classification of lung tumors
2005 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Lung Cancer
2008 Standout
Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens
2001
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
11q13 Allelic Imbalance Discriminates Pulmonary Carcinoids from Tumorlets
1999
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Role of the retinoblastoma protein in the pathogenesis of human cancer.
1997 StandoutNobel
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro‐endocrine lung carcinomas
1994
Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1
2001
Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of α1-Proteinase Inhibitor Generated by Matrix Metalloproteinases
1999
Lung cancer: current therapies and new targeted treatments
2016 Standout
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype
2006
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer
2002
Carcinoid A Comprehensive Review
2003
The microenvironment of the tumour–host interface
2001 StandoutNature
A Translational View of the Molecular Pathogenesis of Lung Cancer
2007
Multifactorial analysis of p53 alteration in human cancer: A review
1994
Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer
2006
VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia
2001
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
EMT: 2016
2016 Standout
Randomized Study of Maintenance Vinorelbine in Responders With Advanced Non-Small-Cell Lung Cancer
2005
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Molecular targeted therapy for carcinoid and islet-cell carcinoma
2007
MicroRNA signatures in human cancers
2006 Standout
A sensitive amperometric immunosensor for carcinoembryonic antigen detection with porous nanogold film and nano-Au/chitosan composite as immobilization matrix
2007
Microtubules as a target for anticancer drugs
2004 Standout
Hypoxia Induces Transcription Factor ETS-1 via the Activity of Hypoxia-Inducible Factor-1
2001
NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin
2008
MYC oncogenes and human neoplastic disease
1999
Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer
1999
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998
Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines
2005
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Angiogenesis as a therapeutic target
2005 StandoutNature
Tumor Angiogenesis
2008 Standout
Cancer of the Ovary
2004 Standout
The multiple roles of tumour stroma
1997
Oral vinorelbine in combination with cisplatin: a novel active regimen in advanced non-small-cell lung cancer
2003
Expression of mdm-2 Protein in Neoplastic, Preneoplastic, and Normal Bronchial Mucosa Specimens: Comparative Study with p53 Expression
1998
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
2000
Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
2007
PET of vascular endothelial growth factor receptor expression.
2006
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Phenotypic consequences of lung-specific inducible expression of FGF-3
2001 StandoutNobel
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
2001
Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non–Small Cell Lung Cancer
2006
Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
2011
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
The ELVIS Trial: A Phase III Study of Single-Agent Vinorelbine as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
2001
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Long Term Analysis of Survival in the European Randomized Trial Comparing Vinorelbine/Cisplatin to Vindesine/Cisplatin and Vinorelbine Alone in Advanced Non-Small Cell Lung Cancer
2001
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Regulation of matrix metalloproteinase expression in tumor invasion
1999 Standout
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Preparing the “Soil”: The Premetastatic Niche
2006
Advances in Copper Complexes as Anticancer Agents
2013 Standout
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
The transcription factor Ets-1 in breast cancer
2005
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
1992 StandoutScience
Works of D Moro being referenced
Basal cell (basaloid) carcinoma of the lung: A new morphologic and phenotypic entity with separate prognostic significance
1992
Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival
1999
E-cadherin-β-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis
2004
Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma.
1991
CEA, CYFRA21-1 and SCC in non-small cell lung cancer
1995
Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: A randomized trial
1994
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
1997
Two-step immunoscintigraphy for non-small-cell lung cancer staging using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
1997
Immunohistochemical study of p53 in human lung carcinomas.
1993
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
1996
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas.
1995
Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study
1997
p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.
1998